DPDelia Mercedes Balarezo Páez

Delia Mercedes Balarezo Páez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Delia Mercedes Balarezo Páez has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Systems Integration in Medicine: The Renal–Gastrointestinal–Urologic Axis as a Framework for Understanding Systemic Disease

    by Juan Antonio Méndez Camargo, Raphaela Ballon Chehade, Christian Gabriel Freire Fiallos, Delia Mercedes Balarezo Páez, María Alejandra Chauran, Uslar Gibran Díaz Maestre, Miguel Sebastián Estrella Silva, Karla Fernanda Villena Proaño

    The interaction between the renal, gastrointestinal, and urologic systems has emerged as a key element in the understanding of systemic diseases. This review aims to analyze and integrate current evidence on inter-organ crosstalk, emphasizing the role of microbiota, metabolic pathways, and immune mechanisms in disease progression. A structured narrative review was conducted using high-impact studies published from 2020 onward, selected from major databases. The findings demonstrate that the gut–kidney axis represents a central pathway, where microbiota-derived metabolites such as uremic toxins contribute to renal dysfunction and systemic inflammation. Additionally, the gastrointestinal tract acts as a reservoir influencing urologic conditions, particularly urinary tract infections. Systemic inflammation and metabolic dysregulation were identified as shared mechanisms linking these organ systems, particularly in chronic conditions such as chronic kidney disease, diabetes mellitus, and metabolic syndrome. The results also highlight the presence of overlapping clinical manifestations and the complexity of therapeutic management, which require a multidisciplinary approach. Regional analysis suggests that these interactions are highly relevant in Latin American contexts, including Mexico, Colombia, and Ecuador, where the burden of chronic disease is significant. In conclusion, the integration of renal, gastrointestinal, and urologic systems into a unified framework provides a more comprehensive understanding of systemic disease and supports the development of more effective clinical strategies. .

  • The Eye as a Diagnostic Window: Advances in Ocular Biomarkers for Systemic Disease Detection

    by Andres Alonso Rojas Trujillo, Jorge Che Enseñat, Zuleika Morales, Jorman Fernando Cazorla Vinueza, Delia Mercedes Balarezo Páez, Loor Zambrano Ney Javier, Jorge Angel Velasco Espinal, Alexa Fernanda Uriostegui Navarro

    Ophthalmology has progressively evolved into a multidisciplinary field with significant potential for systemic disease detection through non-invasive ocular biomarkers. This review aims to analyze current scientific evidence on the relationship between retinal findings and systemic conditions, including cardiovascular, neurodegenerative, metabolic, and renal diseases. A structured narrative review was conducted using high-impact literature published from 2020 onward, focusing on studies indexed in major biomedical databases. The selected evidence was categorized into key domains, including vascular, neurological, metabolic, imaging, and artificial intelligence applications. The findings demonstrate that ocular biomarkers, particularly those derived from retinal imaging modalities such as fundus photography, optical coherence tomography (OCT), and OCT angiography (OCTA), are consistently associated with systemic pathophysiological processes. Strong correlations were identified in neurodegenerative and cardiovascular diseases, where retinal structural and microvascular alterations reflect broader systemic involvement. Additionally, advances in artificial intelligence have enhanced the predictive capacity of ocular imaging, enabling the identification of systemic risk factors through data-driven approaches. Ocular biomarkers also show potential in early detection, risk stratification, and disease monitoring, supporting their integration into preventive medicine frameworks. Despite these advances, challenges related to standardization, reproducibility, and longitudinal validation remain. Overall, the evidence supports the expanding role of ophthalmology as a diagnostic interface for systemic health, with promising applications in both clinical practice and public health, particularly in diverse healthcare settings.

  • Open Access

    Endometriosis as a Model of Systemic Inflammation: Clinical, Molecular, and Translational Implications

    by Augusto Cam Rojas, Daniel Alberto Madrid González, Abdiel Arias Estrada, Perla Gabriela Hershberger Arrechea, Maria Fernanda Venero Acurio, Jorge Angel Velasco Espinal, Delia Mercedes Balarezco Páez, Berenice Lira Hernández

    Endometriosis is increasingly recognized as a systemic inflammatory disease rather than a localized gynecological disorder. This review integrates recent molecular and clinical evidence demonstrating how chronic inflammation, oxidative stress, and extracellular vesicle (EV) signaling interact to shape both local and systemic pathophysiology. Elevated cytokines such as IL-1β, IL-6, TNF-α, IL-8, MCP-1, and VEGF sustain angiogenesis, immune activation, and lesion persistence, while diminished IL-10 impairs immunoregulation. Concurrently, oxidative stress arising from peritoneal iron overload and mitochondrial dysfunction amplifies inflammatory signaling through NF-κB and TGF-β/SMAD pathways, promoting fibrosis, apoptosis resistance, and nociceptor sensitization. Recent discoveries highlight EVs as mediators of systemic communication, transferring microRNAs and proteins that modulate immune, endothelial, and neural targets, thereby linking pelvic inflammation to cardiovascular, metabolic, and autoimmune comorbidities. Evidence from multiple studies indicates that endometriosis confers elevated risks of hypertension, dyslipidemia, autoimmune disorders, and mood disturbances—hallmarks of systemic immune and vascular dysregulation. Furthermore, chronic oxidative and inflammatory exposure fosters genomic instability, explaining the observed association with ovarian clear-cell and endometrioid carcinomas. Recognizing endometriosis as a multisystemic disorder supports the development of integrative diagnostic and therapeutic strategies, including cytokine and exosomal biomarker panels and targeted anti-inflammatory, antioxidant, and anti-angiogenic treatments. Contributions from Mexico, Colombia, and Ecuador emphasize the need for regionally inclusive research and precision-medicine approaches. Endometriosis thus emerges as a model of systemic inflammation, exemplifying how immune, oxidative, and endocrine networks converge to produce both reproductive and extra-pelvic disease manifestations.